TransMedics Group WKN: A2PH5P ISIN: US89377M1099 Kürzel: TMDX Forum: Aktien Thema: Hauptdiskussion

Top aber wann werden die profitabel und sie kämpfen mit Lieferkette Problemen (Fresenius Deutschland, als einziger Lieferant)

TransMedics Reports Second Quarter 2022 Financial Results https://www.prnewswire.com/news-releases/transmedics-reports-second-quarter-2022-financial-results-301597142.html Accelerated Commercial Momentum to Achieve Net Revenue of $20.5 million 2022 Revenue Guidance Range Raised to $67 million to $75 million ...

TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates https://www.nasdaq.com/articles/transmedics-tmdx-reports-q1-loss-tops-revenue-estimates

https://investors.transmedics.com/news-releases/news-release-details/transmedics-reports-first-quarter-2022-financial-results TransMedics Reports First Quarter 2022 Financial Results

TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication https://www.prnewswire.com/news-releases/transmedics-receives-fda-pma-approval-of-ocs-dcd-heart-indication-301535087.html

https://www.massdevice.com/transmedics-rises-as-revenues-top-wall-street-projections/

TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results https://www.prnewswire.com/news-releases/transmedics-reports-fourth-quarter-and-full-year-2021-financial-results-301489026.html

Alle Bio Tech Aktien werden zerstört

TRANSMEDICS POSTS QUARTERLY LOSS PER SHARE OF $0.47 https://www.cmlviz.com/stocks/TMDX/news/b/2021/11/09/transmedics-posts-quarterly-loss-per-share-of-0-47 TransMedics (TMDX) Reports Q3 Loss, Lags Revenue Estimates https://www.nasdaq.com/articles/transmedics-tmdx-reports-q3-loss-lags-revenue-estimates

TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial https://www.prnewswire.com/news-releases/transmedics-announces-positive-top-line-results-from-the-us-randomized-ocs-dcd-heart-trial-301416035.html

TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation https://investors.transmedics.com/news-releases/news-release-details/transmedics-receives-fda-approval-its-ocs-liver-system

TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S. https://finance.yahoo.com/news/transmedics-receives-fda-approval-ocs-110000048.html

Mmmh warum immer noch kein heart approval?!

TransMedics Reports Second Quarter 2021 Financial Results https://newsfilter.io/a/659c857080ad8af25445ce1ae96fad96 ...today reported financial results for the quarter ended June 30, 2021. Recent Highlights • Net revenue of $8.2 million in the second quarter of 2021, representing a 141% increase compared to the second quarter of 2020 • Announced positive FDA advisory committee vote for OCS Liver System • Received FDA 510(k) clearance of the OCS Lung Solution for use in lung transplants using cold storage techniques • OCS Liver PROTECT Trial results presented and recognized as the winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress ...

TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs https://finance.yahoo.com/news/transmedics-receives-fda-clearance-ocs-220500618.html TransMedics to Provide The Most Comprehensive Lung Preservation Product Portfolio to Lung Transplantation Centers in the U.S.

Die Richtung schaut schon mal gut aus: TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System https://www.finanzen.net/nachricht/aktien/transmedics-announces-positive-fda-advisory-committee-vote-for-the-ocs-liver-system-10333852 ...announced today that after review and discussion of TransMedics' clinical evidence from the OCS Liver PROTECT trial, the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee convened by the U.S. Food and Drug Administration ("FDA") has issued a favorable vote in support of approval of the OCS Liver System.   The panel voted 14 to 0, that there is reasonable assurance that the OCS Liver System is effective and 14 to 0, that there is reasonable assurance of the OCS Liver System's safety. The panel voted 12 to 1, with 1 abstaining, that the benefits of the OCS Liver System outweigh its risks. ...